Adam Clemens, MD
Urology · Newark, OHNPI 1477798049
Payments from drug & device makers
Across 85 payments — averaging $64.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neotract Inc.$1K
- Teleflex LLC$931
- Procept Biorobotics Corporation$829
- Boston Scientific$639
- Astellas Pharma US Inc$502
- Dornier Medtech America, Inc$397
- plus $873 from 18 others
What the payments were for
- Travel & lodging$2,30042%
- Food & beverage$2,75750%
- Education$4318%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neotract Inc. | 5 | $1,317 |
| Teleflex LLC | 10 | $931 |
| Procept Biorobotics Corporation | 4 | $829 |
| Boston Scientific | 12 | $639 |
| Astellas Pharma US Inc | 11 | $502 |
| Dornier Medtech America, Inc | 2 | $397 |
| Pfizer | 8 | $163 |
| Laborie Medical Technologies Corp. | 4 | $152 |
| Johnson & Johnson | 5 | $108 |
| Urogen Pharma, Inc. | 5 | $108 |
| Sumitomo Pharma America, Inc. | 2 | $55 |
| AbbVie | 2 | $42 |
| Olympus America Inc. | 2 | $32 |
| Ferring Pharmaceuticals Inc. | 2 | $28 |
| AstraZeneca | 1 | $28 |
| Urovant Sciences Inc | 2 | $27 |
| 180 Medical, Inc. | 1 | $27 |
| Clarus Therapeutics Inc. | 1 | $16 |
| Photocure Inc | 1 | $16 |
| Merck | 1 | $15 |
| Antares Pharma, Inc. | 1 | $15 |
| Bayer | 1 | $15 |
| Coloplast | 1 | $14 |
| Metuchen Pharmaceuticals | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$2,067
- AquaBeam Robotic System$749
- Dornier MedTech$397
- Veozah$128
- Lumenis Pulse 120H$126
- LithoVue$123
- AMS 700 CXR RTE KIT$114
- EUCRISA$112
How this compares
$5,488 in reported general payments places this provider in the 65th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tolterodine Tartrate ErTolterodine Tartrate | 12 | $1,461 |
| Tamsulosin Hcl | 134 | $1,358 |
| Trimethoprim | 16 | $746 |
| Finasteride | 79 | $584 |
| Oxybutynin Chloride | 48 | $280 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $259 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $256 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 45 | $145 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 18 | $134 |
| Cephalexin | 30 | $94 |
| Levofloxacin | 41 | $92 |
| Ciprofloxacin Hcl | 20 | $58 |
Paid to pharmacies, not to this prescriber.
Other urology in Newark
- Marc PliskinCincinnati$20.8M
- Lawrence GervasiMiddleburg Heights$4.7M
- Martin FritzhandCincinnati$4.6M
- Kamal PoharCincinnati$3.4M
- Eric SingerColumbus$2.1M
- Benjamin MartinGahanna$1.1M
- Howard GoldmanCleveland$747K
- Jihad KaoukCleveland$696K
- Raymond RackleyCleveland$695K
- Sandip VasavadaCleveland$512K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.